Menu
Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,166 | Dovepress* | 8,493+ | 866 | 9,359 | |
| PubMed Central* | 673 | 255 | 928 | ||
| Totals | 9,166 | 1,121 | 10,287 | ||
|
*Since 15 December 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar